These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 11388116)
1. Hyperkalemia diagnosed by implantable cardioverter defibrillator T wave sensing. Arthur W; Kaye GC Pacing Clin Electrophysiol; 2001 May; 24(5):908-9. PubMed ID: 11388116 [TBL] [Abstract][Full Text] [Related]
2. Correlation between surface and intracardiac electrocardiogram in a patient with inappropriate defibrillation shocks due to hyperkalemia. Hosaka Y; Chinushi M; Iijima K; Sanada A; Furushima H; Aizawa Y Intern Med; 2009; 48(13):1153-6. PubMed ID: 19571449 [TBL] [Abstract][Full Text] [Related]
3. Use of an electrocardiographic screening tool to determine candidacy for a subcutaneous implantable cardioverter-defibrillator. Groh CA; Sharma S; Pelchovitz DJ; Bhave PD; Rhyner J; Verma N; Arora R; Chicos AB; Kim SS; Lin AC; Passman RS; Knight BP Heart Rhythm; 2014 Aug; 11(8):1361-6. PubMed ID: 24755323 [TBL] [Abstract][Full Text] [Related]
12. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator. Klein HU; Goldenberg I; Moss AJ Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691 [TBL] [Abstract][Full Text] [Related]
13. Electrocardiographic Eligibility for Subcutaneous Implantable Cardioverter Defibrillator: Evaluation during Bicycle Exercise. Ziacchi M; Corzani A; Diemberger I; Martignani C; Marziali A; Mazzotti A; Massaro G; Rapezzi C; Biffi M; Boriani G Heart Lung Circ; 2016 May; 25(5):476-83. PubMed ID: 27044657 [TBL] [Abstract][Full Text] [Related]
14. Triple chamber pacemaker for end-stage heart failure in a patient with a previously implanted automatic defibrillator. Le Franc P; Klug D; Lacroix D; Jarwe M; Kouakam C; Kacet S Pacing Clin Electrophysiol; 1998 Aug; 21(8):1672-5. PubMed ID: 9725169 [TBL] [Abstract][Full Text] [Related]
15. Which patients are not suitable for a subcutaneous ICD: incidence and predictors of failed QRS-T-wave morphology screening. Olde Nordkamp LRA; Warnaars JLF; Kooiman KM; de Groot JR; Rosenmöller BRAM; Wilde AAM; Knops RE J Cardiovasc Electrophysiol; 2014 May; 25(5):494-499. PubMed ID: 24320684 [TBL] [Abstract][Full Text] [Related]
16. Cardiac resynchronization and implantable cardioverter defibrillator therapy: preliminary results from the InSync Implantable Cardioverter Defibrillator Italian Registry. Gasparini M; Lunati M; Bocchiardo M; Mantica M; Gronda E; Frigerio M; Caponi D; Carboni A; Boriani G; Zanotto G; Ravazzi PA; Curnis A; Puglisi A; Klersy C; Vicini I; Cavaglià S Pacing Clin Electrophysiol; 2003 Jan; 26(1P2):148-51. PubMed ID: 12687801 [TBL] [Abstract][Full Text] [Related]
17. Subcutaneous implantable cardioverter-defibrillator: First single-center experience with other cardiac implantable electronic devices. Kuschyk J; Stach K; Tülümen E; Rudic B; Liebe V; Schimpf R; Borggrefe M; Röger S Heart Rhythm; 2015 Nov; 12(11):2230-8. PubMed ID: 26073595 [TBL] [Abstract][Full Text] [Related]
18. Transatrial dual chamber biventricular pacemaker-defibrillator placement in a patient with SVC obstruction. Pua BB; Saunders PC; Lapietra A; Colvin SB; Collins J; Grossi EA Pacing Clin Electrophysiol; 2003 Oct; 26(10):2045-7. PubMed ID: 14516350 [TBL] [Abstract][Full Text] [Related]
19. Hyperkalemia: a dangerous diagnosis for patients with congestive heart failure. Ide B; Drew BJ Prog Cardiovasc Nurs; 1997; 12(4):36-7. PubMed ID: 9433734 [No Abstract] [Full Text] [Related]
20. [Non-pharmacological treatment of heart failure: implantable cardioverter defibrillator (ICD) and cardiac resynchronisation therapy]. van Gelder IC; Smit MD; Nieuwland W; van Veldhuisen DJ Ned Tijdschr Geneeskd; 2006 Oct; 150(41):2238-44. PubMed ID: 17076357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]